Since the type I IFN/IFNAR axis activates a multitude of inflammatory signaling hubs and modulates obesity-associated metabolic derangements in mice, we next examined whether the type I IFN signature32 is altered in the presence of obesity-associated metabolic sequelae. This evidence concerns the gene IFNAR1 and obesity due to melanocortin 4 receptor deficiency.